Making Motion: Support.com (NASDAQ:SPRT), Tremor Video (NYSE:TRMR), Clovis Oncology (NASDAQ:CLVS), Aegean Marine Petroleum Network (NYSE:ANW)

Solar Senior Capital Ltd. (NASDAQ:SUNS) shares moved down -0.62% in last trading session and ended the day at $14.47. SUNS Gross Margin is 67.00% and its has a return on assets of 0.30%. Solar Senior Capital Ltd. (NASDAQ:SUNS) quarterly performance is 1.01%.

Solar Senior Capital (NASDAQ: SUNS) declared a monthly dividend of $0.1175 per share, or $1.41 annualized. The dividend will be payable on May 3, 2016, to stockholders of record on April 21, 2016, with an ex-dividend date of April 19, 2016.

Support.com, Inc. (NASDAQ:SPRT) ended the last trading day at $0.86. Company weekly volatility is calculated as 6.01% and price to cash ratio as 0.72.

Support.com, Inc. (NASDAQ:SPRT), makers of Support.com® Cloud software (formerly “Nexus®”) for Support Interaction Optimization and a leading provider of tech support and turnkey support center services, announced that it plans to release first quarter 2016 financial results after market close on April 27, 2016.

On 08 April, Tremor Video, Inc. (NYSE:TRMR) shares increased 0.99% and was closed at $1.82. Tremor Video, Inc. (NYSE:TRMR) year to date (YTD) performance is -11.76%.

On 29 March, Tremor Video, Inc. (NYSE:TRMR), the premium video marketplace that provides buyers and sellers with software for video ad effectiveness, announced that its Board of Directors has approved a share repurchase program, under which the Company is authorized to purchase up to $15 million of its common stock over the eighteen month period commencing March 25, 2016.

Clovis Oncology, Inc. (NASDAQ:CLVS) shares decreased -17.74% in last trading session and ended the day at $15.77. CLVS has a return on assets of -47.50%. Clovis Oncology, Inc. (NASDAQ:CLVS) quarterly performance is -47.13%.

Clovis Oncology, Inc. (NASDAQ:CLVS) announced that the U.S. Food and Drug Administration (FDA) posted briefing materials in advance of the Oncologic Drugs Advisory Committee (ODAC) meeting to discuss accelerated approval of the New Drug Application (NDA) for rociletinib, an investigational therapy for the treatment of patients with mutant epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC) who have been previously treated with an EGFR-targeted therapy and have the T790M mutation.

Aegean Marine Petroleum Network Inc. (NYSE:ANW) caters to the Basic Materials space. Its weekly performance is 1.64%. On the last day of trading company shares ended up at $7.44. Aegean Marine Petroleum Network Inc. (NYSE:ANW) distance from 50-day simple moving average (SMA50) is 4.25%.

On 23 March, Aegean Marine Petroleum Network Inc. (NYSE:ANW) announced that it is launching a bunkering operation in Algoa Bay, near the port[s] of Port Elizabeth, South Africa and Coega, South Africa. Located within a few miles of heavily trafficked international shipping lanes, the new bunkering operation is well positioned as a natural stopover on routes to Europe, the Americas, Asia, Australia and both coasts of Africa.